Skip Navigation

British Journal of Anaesthesia 2006 97(1):116-117; doi:10.1093/bja/ael124
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow E-letters: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bloomfield, R.
Right arrow Articles by Noble, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloomfield, R.
Right arrow Articles by Noble, D. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Etomidate and fatal outcome—even a single bolus dose may be detrimental for some patients

The first 10% of the full text of this article appears below.

Editor—Etomidate has been used for over a quarter of a century in many countries in a variety of anaesthetic and non-anaesthetic settings. Despite problems such as pain on injection, thrombophlebitis and myoclonus, the positive pharmacologic attributes of etomidate have contributed to its continued use. The effect on cardiac output and myocardial oxygenation and its wide therapeutic index, which is approximately 6-fold better than thiopental and propofol, have logically . . . [Full Text of this Article]

R. Bloomfield and D. W. Noble*

Aberdeen, UK

*E-mail: d.noble@nhs.net


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Emerg. Med. J.Home page
C R W Baird, A W Hay, D W McKeown, and D C Ray
Rapid sequence induction in the emergency department: induction drug and outcome of patients admitted to the intensive care unit
Emerg. Med. J., August 1, 2009; 26(8): 576 - 579.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. M. Walz, M. Zayaruzny, and S. O. Heard
Airway Management in Critical Illness
Chest, February 1, 2007; 131(2): 608 - 620.
[Abstract] [Full Text] [PDF]

E-letters:

Read all E-letters

Fatal flaws in the case against etomidate for induction
Thomas A Crozier
British Journal of Anaesthesia, 29 Aug 2006 [Full text]
Etomidate - audit of outcomes
Seema Quasim, et al.
British Journal of Anaesthesia, 2 Apr 2007 [Full text]